GL1X · GenesisL1 explorer

Research workbench

GLUA2FLIP slbd complexed with fw and (R,R)-2B crystal form E

Analyse GLUA2FLIP slbd complexed with fw and (R,R)-2B crystal form E in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4U21
Type
protein
Length
522 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glutamate receptor 2,GLUTAMATE receptor 2
UniProt
P19491
Ligands
FWD, FWF
Pockets
4 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 37% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlutamate receptor 2,GLUTAMATE receptor 2protein26237% helix, 20% strandP19491
BGlutamate receptor 2,GLUTAMATE receptor 2protein26037% helix, 21% strandP19491

Ligands and binding sites

  • FWD · 2-amino-3-(5-fluoro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-propionic acid · ligand · 2 copies · chains A, B
  • FWF · N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19200.790.8293FWF
23130.610.7936empty
31060.410.7625empty
4920.400.7723empty

Interfaces

1 interface between chains.

  • A–B · 838 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 4U21 · GluA2flip sLBD complexed with FW and (R,R)-2b crystal form E · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.